Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $107,168
Reuters2026/08/18 20:13- Aquestive Therapeutics President and CEO Daniel Barber sold 25,000 common shares on Aug. 17, 2026.
- Sale priced at a weighted average of $4.29 per share.
- Post-transaction holding reported at 585,574 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Corpay Group President Alan King sells USD 9.25 million in common shares
AI Data Center "Power Shortage" Boosts Demand for Traditional Power Assets; Private Equity Giant KKR (KKR.US) Plans to Acquire UGI (UGI.US), a US Energy Distributor, for $9 Billion
According to reports, private equity giant KKR recently submitted a non-binding acquisition proposal to natural gas and electricity distributor UGI Utilities, with the deal valued at approximately 9 billion dollars.
Lumentum SVP, General Counsel Jae Kim reports disposal of common shares worth $3.48 million
Samsung Electronics invests KRW 240 billion to build HVAC production line in Korea by 2028
Crypto prices
More
